These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 12491521)

  • 1. Circulating 92-kilodalton matrix metalloproteinase (MMP-9) activity is enhanced in the euglobulin plasma fraction of head and neck squamous cell carcinoma.
    Mannello F
    Cancer; 2003 Jan; 97(1):201-3; author reply 203-4. PubMed ID: 12491521
    [No Abstract]   [Full Text] [Related]  

  • 2. Serum levels of matrix metalloproteinase-2 and -9 in patients with head and neck squamous cell carcinoma.
    Riedel F; Götte K; Schwalb J; Hörmann K
    Anticancer Res; 2000; 20(5A):3045-9. PubMed ID: 11062721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significant correlation of matrix metalloproteinase and macrophage colony-stimulating factor serum concentrations in patients with head and neck cancer.
    Kuropkat C; Duenne AA; Herz U; Renz H; Werner JA
    Neoplasma; 2004; 51(5):375-8. PubMed ID: 15640942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of MMP-2, -9 and -13 in cell lines and fresh biopsies of squamous cell carcinomas of the upper aerodigestive tract.
    Dünne AA; Sesterhenn A; Gerisch A; Teymoortash A; Kuropkat C; Werner JA
    Anticancer Res; 2003; 23(3B):2233-9. PubMed ID: 12894497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating 92-kilodalton matrix metalloproteinase (MMP-9) activity is enhanced in the euglobulin plasma fraction of head and neck squamous cell carcinoma.
    Ranuncolo SM; Matos E; Loria D; Vilensky M; Rojo R; Bal de Kier Joffé E; Inés Puricelli L
    Cancer; 2002 Mar; 94(5):1483-91. PubMed ID: 11920505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Usefulness of neuron specific enolase in patients with head and neck malignant tumors].
    Adamiak G; Ligeziński A; Jurkiewicz D; Hermanowski M; Konieczna M
    Pol Merkur Lekarski; 2002 Mar; 12(69):204-7. PubMed ID: 12053589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The usefulness of new serum tumor markers in head and neck squamous cell carcinoma.
    Marcos CA; Martínez DA; de Los Toyos JR; Domínguez Iglesias F; Hermsen M; Guervós MA; Pendás JL
    Otolaryngol Head Neck Surg; 2009 Mar; 140(3):375-80. PubMed ID: 19248946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metaanalysis of the significance of matrix metalloproteinases for lymph node disease in patients with head and neck squamous cell carcinoma.
    Wiegand S; Dünne AA; Müller HH; Mandic R; Barth P; Davis RK; Werner JA
    Cancer; 2005 Jul; 104(1):94-100. PubMed ID: 15912516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tissue MMP-2 and MMP-9 [corrected] are better prognostic factors than serum MMP-2/TIMP-2--complex or TIMP-1 [corrected] in stage [corrected] I-III lung carcinoma.
    Hoikkala S; Pääkkö P; Soini Y; Mäkitaro R; Kinnula V; Turpeenniemi-Hujanen T
    Cancer Lett; 2006 May; 236(1):125-32. PubMed ID: 15982804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of MMP-7 and MT1-MMP in oral squamous cell carcinoma as predictive indicator for tumor invasion and prognosis.
    de Vicente JC; Lequerica-Fernández P; Santamaría J; Fresno MF
    J Oral Pathol Med; 2007 Aug; 36(7):415-24. PubMed ID: 17617835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of matrix metalloproteinase (MMP)-1 promoter polymorphism with head and neck squamous cell carcinoma.
    Hashimoto T; Uchida K; Okayama N; Imate Y; Suehiro Y; Hamanaka Y; Ueyama Y; Shinozaki F; Yamashita H; Hinoda Y
    Cancer Lett; 2004 Jul; 211(1):19-24. PubMed ID: 15194213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression and clinical significance of matrix metalloproteinase-2 and matrix metalloproteinase-9 in oral squamous cell carcinoma.
    de Vicente JC; Fresno MF; Villalain L; Vega JA; Hernández Vallejo G
    Oral Oncol; 2005 Mar; 41(3):283-93. PubMed ID: 15743691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metalloproteinases and their inhibitors: influence on tumor invasiveness and metastasis formation in head and neck squamous cell carcinomas.
    Görögh T; Beier UH; Bäumken J; Meyer JE; Hoffmann M; Gottschlich S; Maune S
    Head Neck; 2006 Jan; 28(1):31-9. PubMed ID: 16265652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Expression of ETV5 and MMP-7 in early stage cervical squamous cell carcinoma and its role in lymphatic metastasis].
    Wu SH; Zhang J; Li Y; Li JM
    Ai Zheng; 2006 Mar; 25(3):315-9. PubMed ID: 16536985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of matrix metalloproteinases in supraglottic carcinoma and its clinical implication for estimating lymph node metastases.
    Xie M; Sun Y; Li Y
    Laryngoscope; 2004 Dec; 114(12):2243-8. PubMed ID: 15564854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Determination of plasminogen activator of the head and neck tumor tissue].
    Ji X; Nong H; Huang G
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 1994; 29(5):299-301. PubMed ID: 7718296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Staging of the neck in patients with head and neck squamous cell cancer: imaging techniques and biomarkers.
    Takes RP
    Oral Oncol; 2004 Aug; 40(7):656-67. PubMed ID: 15172634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The matrix metalloproteinase system in oral squamous cell carcinoma.
    Baker EA; Leaper DJ; Hayter JP; Dickenson AJ
    Br J Oral Maxillofac Surg; 2006 Dec; 44(6):482-6. PubMed ID: 16338034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble interleukin-2 receptor and metalloproteinase-9 expression in head and neck cancer: prognostic value and analysis of their relationships.
    El Houda Agueznay N; Badoual C; Hans S; Gey A; Vingert B; Peyrard S; Quintin-Colonna F; Ravel P; Bruneval P; Roncelin S; Lelongt B; Bertoglio J; Fridman WH; Brasnu D; Tartour E
    Clin Exp Immunol; 2007 Oct; 150(1):114-23. PubMed ID: 17680822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma matrix metalloproteinase-9 level is better than serum matrix metalloproteinase-9 level to predict gastric cancer evolution.
    Wu CY; Wu MS; Chiang EP; Chen YJ; Chen CJ; Chi NH; Shih YT; Chen GH; Lin JT
    Clin Cancer Res; 2007 Apr; 13(7):2054-60. PubMed ID: 17404086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.